−380KRW
−13.88 BKRW
69.37 BKRW
25.21 M
About EUBIO
Sector
CEO
Yeong-Ok Baek
Headquarters
Seoul
Website
Employees (FY)
321
Founded
2010
ISIN
KR7206650004
FIGI
BBG00F90XZ93
EuBiologics Co., Ltd. engages in the research, development, and manufacture of biopharmaceutical products. It offers comprehensive contract research organization and contract manufacturing organization services. Its products include Euvichol, oral cholera vaccine, enteric infection vaccine, and anti-cancer vaccine. The company was founded on March 10, 2010 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 206650 is 12710 KRW — it has increased by 0.39% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange EUBIO stocks are traded under the ticker 206650.
206650 stock is 7.40% volatile and has beta coefficient of 1.07. Check out the list of the most volatile stocks — is EUBIO there?
One year price forecast for EUBIO has a max estimate of 15000 KRW and a min estimate of 14000 KRW.
EUBIO revenue for the last quarter amounts to 5.90 B KRW despite the estimated figure of 5.60 B KRW. In the next quarter revenue is expected to reach 26.90 B KRW.
Yes, you can track EUBIO financials in yearly and quarterly reports right on TradingView.
206650 stock has risen by 6.27% compared to the previous week, the month change is a 4.61% rise, over the last year EUBIO has showed a 58.88% increase.
206650 net income for the last quarter is −12.71 B KRW, while the quarter before that showed −3.10 B KRW of net income which accounts for −309.76% change. Track more EUBIO financial stats to get the full picture.
Today EUBIO has the market capitalization of 461.52 B, it has decreased by 0.99% over the last week.
No, 206650 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 206650 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EUBIO stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 321.00 employees. See our rating of the largest employees — is EUBIO on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EUBIO technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EUBIO stock shows the buy signal. See more of EUBIO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on EUBIO future price: according to them, 206650 price has a max estimate of 15000.00 KRW and a min estimate of 14000.00 KRW. Read a more detailed EUBIO forecast: see what analysts think of EUBIO and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EUBIO EBITDA is 16.87 B KRW, and current EBITDA margin is 24.32%. See more stats in EUBIO financial statements.